Evidence map›Paper›PMID 40487156›Full record

ArticleMaterials today. Bio2025

Curcumin-encapsulated exosomes in bisphosphonate-modified hydrogel microspheres promote bone repair through macrophage polarization and DNA damage mitigation.

Yunhui Si, Shuao Dong, Mengsha Li, Jiaying Gu, Manxuan Luo, Xiaohan Wang, Zhiwei Wang, Xiaorong Li, Chao Zhang

Abstract read
In one paragraph

Article in Materials today. Bio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Applications of DNA Hydrogels in Osteoporotic Bone Defects.Journal of functional biomaterials · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Recent Advances in Nanozymes Toward Diabetic Foot Ulcers.International journal of nanomedicine · 2026
    Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yunhui SiSchool of Biomedical Engineering, Shenzhen Campus of Sun Yat-sen University, Shenzhen, Guangdong, 518107, PR China.
Shuao DongSchool of Biomedical Engineering, Shenzhen Campus of Sun Yat-sen University, Shenzhen, Guangdong, 518107, PR China.
Mengsha LiSchool of Materials Science and Engineering, Sun Yat-sen University, Guangzhou, Guangdong, 510275, PR China.
Jiaying GuSchool of Biomedical Engineering, Shenzhen Campus of Sun Yat-sen University, Shenzhen, Guangdong, 518107, PR China.
Manxuan LuoThe Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, Guangdong, 518107, PR China.
Xiaohan WangThe Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, Guangdong, 518107, PR China.
Zhiwei WangSouthern Marine Science and Engineering Guangdong Laboratory (Zhuhai), Zhuhai, Guangdong, 519000, PR China.
Xiaorong LiThe Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, Guangdong, 518107, PR China.
Chao ZhangSchool of Biomedical Engineering, Shenzhen Campus of Sun Yat-sen University, Shenzhen, Guangdong, 518107, PR China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Repairing critical-sized bone defects represents a major challenge in clinical therapeutics due to inhibited osteogenic differentiation, harsh bone tissue microenvironment, and abnormal inflammatory response. Mesenchymal stem cell-derived exosomes (MSC-Exos) have demonstrated tremendous regenerative potential in tissue repair. However, the confined therapeutic efficacy, deficient targeting capability, and poor retention rate have rendered MSC-Exos-based cell-free therapies insufficient for clinical bone defect repair. This study prepared curcumin-loaded MSC-Exos (Cur@Exos) based on an endogenous drug delivery approach and encapsulated in bisphosphonate-modified GelMA hydrogel microspheres by microfluidics. The CE@BP-Gel microspheres demonstrated superior biocompatibility and were competent to accelerate biomineralization. The sustained-release Cur@Exos in the composite hydrogel microspheres actively regulated the polarization of RAW264.7 cells toward the regenerative M2 type and inhibited the osteoclastic activity, thereby creating an immune microenvironment suitable for osteogenesis. Meanwhile, the composite hydrogel microspheres can directly support the adhesion, proliferation and osteogenic differentiation of BMSCs and facilitate the migration and angiogenesis of HUVECs.

Indexed as

CurcuminHydrogelImmunomodulationMSC-ExosOsteogenesis

Identifiers

PMID40487156
PMCPMC12145554

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.